array:19 [
  "pii" => "X0211699500025592"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2000-02-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2000;20 Supl 1:51"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1386
    "formatos" => array:3 [
      "EPUB" => 148
      "HTML" => 974
      "PDF" => 264
    ]
  ]
  "itemSiguiente" => array:15 [
    "pii" => "X0211699500025584"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:52-3"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2209
      "formatos" => array:3 [
        "EPUB" => 177
        "HTML" => 1679
        "PDF" => 353
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "«CONTROL DE LA PRESIÓN ARTERIAL EN LA ENFERMEDAD RENAL» Prevalencia y control de la hipertensión arterial en los pacientes con enfermedad renal"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "52"
          "paginaFinal" => "53"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J. LUÑO , A. TEJEDOR , S. GARCÍA DE VINUESA , F. VALDERRÁBANO , F. GÓMEZ CAMPDERÁ , N. RIDAO , M. SÁNCHEZ"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "J. LUÑO , A. TEJEDOR , S. GARCÍA DE VINUESA , F. VALDERRÁBANO , F. GÓMEZ CAMPDERÁ , N. RIDAO , M. SÁNCHEZ"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025584?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025584/v0_201502091333/es/main.assets"
  ]
  "itemAnterior" => array:15 [
    "pii" => "X0211699500025607"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:50"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1352
      "formatos" => array:3 [
        "EPUB" => 153
        "HTML" => 915
        "PDF" => 284
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Role of the renin-angiotensin system in the progression of renal disease"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "50"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J. EGIDO , M. RUIZ-ORTEGA , O. LORENZO , Y. SUZUKI , A. GATICA"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "J. EGIDO , M. RUIZ-ORTEGA , O. LORENZO , Y. SUZUKI , A. GATICA"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025607?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025607/v0_201502091333/en/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "The Endothelium in the Progression of Renal Failure: Therapeutic Implications"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "51"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "L. RAIJ"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "L. RAIJ"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Vol. XX. Suplemento 1. 2000 The Endothelium in the Progression of Renal Failure: Therapeutic Implications L. Raij Veterans Affairs Medical Center. Minneapolis. USA. Anatomically, the glomerulus is composed of the glomerular basement membrane (GBM)&#59; the epithelial cells, which outline the GBM in the urinary space&#59; and the mesangium, which lies in an intracapillary position and forms the glomerular centrolobular area. The direct juxtaposition of endothelial and mesangial cells facilitates products synthesized by these cells to reach each other in high concentrations. Similar to vascular smooth muscle, mesangial cells contain actin-myosin filaments and change their contractile state in response to vasoactive substances. Thus, agents such as angiotensin II (AII), eicosanoids, endothelin-1 (ET-1), and nitric oxide (NO) synthesized and released locally can act on these cells in an autocrine and/or paracrine fashion. In the glomerulus, vasoactive agents acting upon the mesangium and/or the afferent and efferent arteriole can modulate the glomerular microcirculation under physiologic and pathologic conditions. Moreover, similar to what occurs in systemic vascular beds, the nonhemodynamic actions of vasoactive agents may also participate in the response of glomerular cells to injury and result in architectural changes of the glomerulus, such as mesangial hypertrophy and/or hyperplasia, as well as in increased mesangial cell matrix production. Increased renal actions of Ang II or NO may be due to an actual increase in the local concentration of the individual agent and/or to a concomitant decrease in the concentration of the other. Moreover, chronic NO synthesis inhibition induces glomerular and tubulointerstitial injury as well as coronary vasCorrespondence: L. Raij, M. D. Chief, Nephrology/Hypertension Professor of Medicine, University of Minnesota VA Medical Center One Veterans Drive Minneapolis, MN 55417 USA cular remodeling and LVH that is accompanied by increased ACE expression and activity. This would suggest that decreased vascular NO bioactivity due to endothelial dysfunction as seen in hypertension may promote vascular hypertrophy due to combined deficit of NO and local excess of Ang II. Indeed, experimentally, in vivo transfection of excess ACE to arterial segments results in localized vascular hypertrophy mediated by Ang II. Ang II has been reported to activate NADH/NADPH oxidase in vascular smooth muscle cells and more recently in mesangial cells, leading to the cells' protracted synthesis of O2-. O2- has great affinity for NO, causing interaction between the two and resulting in either NO inactivation or the production of toxic peroxynitrite. Furthermore, in the glomerulus as in the vasculature in general, decreased NO bioactivity not only reduces the ability of NO to counteract Ang II actions on vascular tone but also diminishes the homeostatic role of NO in preventing vascular thrombosis, leukocyte adhesion to endothelium, and Ang II-driven mesangial cell hypertrophy/hyperplasia and production of extracellular matrix. ET-1, a powerful vasoconstrictor, is capable of reducing renal blood flow and glomerular filtration rate by acting on preglomerular resistances and inducing mesangial cell contraction. The interaction between NO and ET-1 appears to be more important under pathological than under physiological conditions. In addition, ET-1 synthesis is upregulated by Ang II and downregulated by NO. ET-1 may thus play its role late rather than early in renal pathophysiological processes in that its importance may build as the renal bioactivity of NO decreases. From a therapeutic point of view antihypertensive agents that interfere with the local renin-angiotenisnendothelial system are the best choices for arresting the hemodynamic and nonhemodynamic factors that promote the progression of renal failure. 51 "
    "pdfFichero" => "P7-E170-S140-A1895.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025592/v0_201502091333/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35407"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Suplementos"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/00000020000000S1/v0_201502091333/X0211699500025592/v0_201502091333/en/P7-E170-S140-A1895.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025592?idApp=UINPBA000064"
]
Compartir
Información de la revista

Estadísticas

Siga este enlace para acceder al texto completo del artículo

The Endothelium in the Progression of Renal Failure: Therapeutic Implications
L. RAIJ
Leído
3745
Veces
se ha leído el artículo
1515
Total PDF
2230
Total HTML
Compartir estadísticas
 array:19 [
  "pii" => "X0211699500025592"
  "issn" => "02116995"
  "estado" => "S300"
  "fechaPublicacion" => "2000-02-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia. 2000;20 Supl 1:51"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1386
    "formatos" => array:3 [
      "EPUB" => 148
      "HTML" => 974
      "PDF" => 264
    ]
  ]
  "itemSiguiente" => array:15 [
    "pii" => "X0211699500025584"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:52-3"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2209
      "formatos" => array:3 [
        "EPUB" => 177
        "HTML" => 1679
        "PDF" => 353
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "«CONTROL DE LA PRESIÓN ARTERIAL EN LA ENFERMEDAD RENAL» Prevalencia y control de la hipertensión arterial en los pacientes con enfermedad renal"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "52"
          "paginaFinal" => "53"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J. LUÑO , A. TEJEDOR , S. GARCÍA DE VINUESA , F. VALDERRÁBANO , F. GÓMEZ CAMPDERÁ , N. RIDAO , M. SÁNCHEZ"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "J. LUÑO , A. TEJEDOR , S. GARCÍA DE VINUESA , F. VALDERRÁBANO , F. GÓMEZ CAMPDERÁ , N. RIDAO , M. SÁNCHEZ"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025584?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025584/v0_201502091333/es/main.assets"
  ]
  "itemAnterior" => array:15 [
    "pii" => "X0211699500025607"
    "issn" => "02116995"
    "estado" => "S300"
    "fechaPublicacion" => "2000-02-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia. 2000;20 Supl 1:50"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1352
      "formatos" => array:3 [
        "EPUB" => 153
        "HTML" => 915
        "PDF" => 284
      ]
    ]
    "en" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Role of the renin-angiotensin system in the progression of renal disease"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "50"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J. EGIDO , M. RUIZ-ORTEGA , O. LORENZO , Y. SUZUKI , A. GATICA"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "J. EGIDO , M. RUIZ-ORTEGA , O. LORENZO , Y. SUZUKI , A. GATICA"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025607?idApp=UINPBA000064"
    "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025607/v0_201502091333/en/main.assets"
  ]
  "en" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "The Endothelium in the Progression of Renal Failure: Therapeutic Implications"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "51"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "L. RAIJ"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "L. RAIJ"
          ]
        ]
      ]
    ]
    "textoCompleto" => "NEFROLOGÍA. Vol. XX. Suplemento 1. 2000 The Endothelium in the Progression of Renal Failure: Therapeutic Implications L. Raij Veterans Affairs Medical Center. Minneapolis. USA. Anatomically, the glomerulus is composed of the glomerular basement membrane (GBM)&#59; the epithelial cells, which outline the GBM in the urinary space&#59; and the mesangium, which lies in an intracapillary position and forms the glomerular centrolobular area. The direct juxtaposition of endothelial and mesangial cells facilitates products synthesized by these cells to reach each other in high concentrations. Similar to vascular smooth muscle, mesangial cells contain actin-myosin filaments and change their contractile state in response to vasoactive substances. Thus, agents such as angiotensin II (AII), eicosanoids, endothelin-1 (ET-1), and nitric oxide (NO) synthesized and released locally can act on these cells in an autocrine and/or paracrine fashion. In the glomerulus, vasoactive agents acting upon the mesangium and/or the afferent and efferent arteriole can modulate the glomerular microcirculation under physiologic and pathologic conditions. Moreover, similar to what occurs in systemic vascular beds, the nonhemodynamic actions of vasoactive agents may also participate in the response of glomerular cells to injury and result in architectural changes of the glomerulus, such as mesangial hypertrophy and/or hyperplasia, as well as in increased mesangial cell matrix production. Increased renal actions of Ang II or NO may be due to an actual increase in the local concentration of the individual agent and/or to a concomitant decrease in the concentration of the other. Moreover, chronic NO synthesis inhibition induces glomerular and tubulointerstitial injury as well as coronary vasCorrespondence: L. Raij, M. D. Chief, Nephrology/Hypertension Professor of Medicine, University of Minnesota VA Medical Center One Veterans Drive Minneapolis, MN 55417 USA cular remodeling and LVH that is accompanied by increased ACE expression and activity. This would suggest that decreased vascular NO bioactivity due to endothelial dysfunction as seen in hypertension may promote vascular hypertrophy due to combined deficit of NO and local excess of Ang II. Indeed, experimentally, in vivo transfection of excess ACE to arterial segments results in localized vascular hypertrophy mediated by Ang II. Ang II has been reported to activate NADH/NADPH oxidase in vascular smooth muscle cells and more recently in mesangial cells, leading to the cells' protracted synthesis of O2-. O2- has great affinity for NO, causing interaction between the two and resulting in either NO inactivation or the production of toxic peroxynitrite. Furthermore, in the glomerulus as in the vasculature in general, decreased NO bioactivity not only reduces the ability of NO to counteract Ang II actions on vascular tone but also diminishes the homeostatic role of NO in preventing vascular thrombosis, leukocyte adhesion to endothelium, and Ang II-driven mesangial cell hypertrophy/hyperplasia and production of extracellular matrix. ET-1, a powerful vasoconstrictor, is capable of reducing renal blood flow and glomerular filtration rate by acting on preglomerular resistances and inducing mesangial cell contraction. The interaction between NO and ET-1 appears to be more important under pathological than under physiological conditions. In addition, ET-1 synthesis is upregulated by Ang II and downregulated by NO. ET-1 may thus play its role late rather than early in renal pathophysiological processes in that its importance may build as the renal bioactivity of NO decreases. From a therapeutic point of view antihypertensive agents that interfere with the local renin-angiotenisnendothelial system are the best choices for arresting the hemodynamic and nonhemodynamic factors that promote the progression of renal failure. 51 "
    "pdfFichero" => "P7-E170-S140-A1895.pdf"
    "tienePdf" => true
  ]
  "idiomaDefecto" => "en"
  "url" => "/02116995/00000020000000S1/v0_201502091333/X0211699500025592/v0_201502091333/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35407"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Suplementos"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02116995/00000020000000S1/v0_201502091333/X0211699500025592/v0_201502091333/en/P7-E170-S140-A1895.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699500025592?idApp=UINPBA000064"
]
Información del artículo
ISSN: 02116995
Idioma original: Inglés
Datos actualizados diariamente
año/Mes Html Pdf Total
2024 Noviembre 8 7 15
2024 Octubre 31 34 65
2024 Septiembre 30 26 56
2024 Agosto 45 42 87
2024 Julio 43 31 74
2024 Junio 35 25 60
2024 Mayo 43 34 77
2024 Abril 29 15 44
2024 Marzo 23 23 46
2024 Febrero 30 34 64
2024 Enero 14 14 28
2023 Diciembre 16 20 36
2023 Noviembre 23 27 50
2023 Octubre 23 22 45
2023 Septiembre 20 32 52
2023 Agosto 21 25 46
2023 Julio 26 26 52
2023 Junio 28 19 47
2023 Mayo 23 27 50
2023 Abril 15 16 31
2023 Marzo 11 16 27
2023 Febrero 17 14 31
2023 Enero 22 21 43
2022 Diciembre 22 30 52
2022 Noviembre 24 26 50
2022 Octubre 25 27 52
2022 Septiembre 26 16 42
2022 Agosto 21 30 51
2022 Julio 26 38 64
2022 Junio 22 26 48
2022 Mayo 34 32 66
2022 Abril 30 30 60
2022 Marzo 29 39 68
2022 Febrero 33 25 58
2022 Enero 26 25 51
2021 Diciembre 16 36 52
2021 Noviembre 23 29 52
2021 Octubre 21 31 52
2021 Septiembre 15 26 41
2021 Agosto 15 23 38
2021 Julio 19 34 53
2021 Junio 11 8 19
2021 Mayo 15 21 36
2021 Abril 19 35 54
2021 Marzo 15 11 26
2021 Febrero 21 10 31
2021 Enero 7 12 19
2020 Diciembre 19 8 27
2020 Noviembre 13 5 18
2020 Octubre 11 6 17
2020 Septiembre 8 8 16
2020 Agosto 17 7 24
2020 Julio 18 5 23
2020 Junio 20 5 25
2020 Mayo 15 11 26
2020 Abril 21 9 30
2020 Marzo 9 10 19
2020 Febrero 22 11 33
2020 Enero 25 13 38
2019 Diciembre 15 10 25
2019 Noviembre 5 0 5
2019 Octubre 8 6 14
2019 Septiembre 11 13 24
2019 Agosto 7 11 18
2019 Julio 11 10 21
2019 Junio 5 5 10
2019 Mayo 10 6 16
2019 Abril 18 24 42
2019 Marzo 9 8 17
2019 Febrero 6 12 18
2019 Enero 9 7 16
2018 Diciembre 24 17 41
2018 Noviembre 24 7 31
2018 Octubre 16 5 21
2018 Septiembre 16 7 23
2018 Agosto 13 7 20
2018 Julio 15 6 21
2018 Junio 10 5 15
2018 Mayo 10 8 18
2018 Abril 16 3 19
2018 Marzo 8 4 12
2018 Febrero 13 4 17
2018 Enero 9 3 12
2017 Diciembre 11 8 19
2017 Noviembre 15 2 17
2017 Octubre 14 4 18
2017 Septiembre 8 5 13
2017 Agosto 15 7 22
2017 Julio 7 2 9
2017 Junio 9 3 12
2017 Mayo 5 0 5
2017 Abril 9 8 17
2017 Marzo 2 6 8
2017 Febrero 7 2 9
2017 Enero 3 1 4
2016 Diciembre 16 2 18
2016 Noviembre 17 2 19
2016 Octubre 21 5 26
2016 Septiembre 20 1 21
2016 Agosto 61 1 62
2016 Julio 41 0 41
2016 Junio 49 0 49
2016 Mayo 56 0 56
2016 Abril 38 0 38
2016 Marzo 18 0 18
2016 Febrero 30 0 30
2016 Enero 13 0 13
2015 Diciembre 36 0 36
2015 Noviembre 24 0 24
2015 Octubre 22 0 22
2015 Septiembre 26 0 26
2015 Agosto 20 0 20
2015 Julio 20 0 20
2015 Junio 7 0 7
2015 Mayo 13 0 13
Mostrar todo

Siga este enlace para acceder al texto completo del artículo

Idiomas
Nefrología
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?